Pharmaceuticals

Electrocompetent Cells Industry Poised for Rapid Growth, Forecast to Touch $2.51 Billion by 2030 at 9.8% CAGR

February 13, 2026February 13, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the electrocompetent cells market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Electrocompetent Cells Market from 2026 to 2030?

The market size for electrocompetent cells has experienced significant expansion in recent years. It is projected to climb from $1.57 billion in 2025 to $1.73 billion in 2026, advancing at a compound annual growth rate (CAGR) of 10.0%. The growth observed historically can be attributed to factors such as the expansion of molecular biology research, a rise in the utilization of plasmid cloning, the establishment of more academic research institutes, an increasing demand for recombinant proteins, and the implementation of electroporation techniques.

The electrocompetent cells market is projected to experience substantial growth in the coming years. It is forecast to expand to $2.51 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.8%. This expansion during the forecast period is driven by factors such as the advancement of gene therapy research, an increase in CRISPR-based studies, the broadening of biotechnology pipelines, a rise in outsourcing to CROs, and the demand for high-throughput genetic engineering. Prominent trends for this period involve an escalating need for high-efficiency transformation cells, their wider application in gene editing, growing integration into synthetic biology research, the availability of more custom and ready-to-use cell formats, and their increased use in therapeutic development.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24214&type=smp

What Drivers Are Affecting Demand In The Electrocompetent Cells Market?

The electrocompetent cells market is anticipated to grow significantly due to the increasing demand for genetic engineering, a process that intentionally modifies an organism’s genetic material to change its traits or behavior. The expansion of genetic engineering is driven by the need for greater agricultural productivity, facilitating the creation of crops with improved yields and pest resistance, which helps reduce dependence on chemicals. This escalating need for genetic engineering in turn boosts the demand for electrocompetent cells, which are essential for efficient DNA transformation. With genetic modifications becoming more widespread across research, healthcare, and agriculture, the requirement for premium electrocompetent cells is on the rise. For instance, in April 2025, the Economic Research Service, a US-based government agency, reported that in 2024, genetically engineered, insect-resistant seeds were used on 90 percent of cotton acres in the U.S. Hence, the increasing adoption of genetic engineering is a primary catalyst for the growth of the electrocompetent cells market.

Which Segment Groups Are Influencing The Electrocompetent Cells Market?

The electrocompetent cells market covered in this report is segmented –

1) By Product Type: Bacterial Electrocompetent Cells, Yeast Electrocompetent Cells, Plant Electrocompetent Cells, Mammalian Electrocompetent Cells

2) By Technology: Electroporation Technology, Chemical Transformation Technology, Other Technologies

3) By Packaging Format: Tubes, Plates, Custom Formats

4) By Application: Gene Cloning, Protein Expression, Transfection Studies, Gene Editing, Therapeutic Applications, Other Applications

5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs), Other End-Users

Subsegments:

1) By Bacterial Electrocompetent Cells: E. coli Electrocompetent Cells, Salmonella Electrocompetent Cells, Clostridium Electrocompetent Cells, Bacillus Electrocompetent Cells

2) By Yeast Electrocompetent Cells: Saccharomyces Cerevisiae Electrocompetent Cells, Pichia Pastoris Electrocompetent Cells, Schizosaccharomyces Pombe Electrocompetent Cells

3) By Plant Electrocompetent Cells: Arabidopsis Thaliana Electrocompetent Cells, Nicotiana Benthamiana Electrocompetent Cells, Maize Electrocompetent Cells

4) By Mammalian Electrocompetent Cells: HEK293 Electrocompetent Cells, Chinese Hamster Ovary (CHO) Electrocompetent Cells, NIH 3T3 Electrocompetent Cells

Which Innovation Trends Are Advancing Developments Within The Electrocompetent Cells Market?

Major companies within the electrocompetent cells market are actively pursuing the creation of advanced solutions, such as automated cell processing technology, with the aim of enhancing scalability in genetic engineering workflows. This automated cell processing technology leverages software-driven systems to oversee the handling, cultivation, modification, and preservation of cells, requiring minimal human intervention. Such an approach significantly improves operational efficiency, promotes standardization, and offers greater scalability across fields like cell therapy, regenerative medicine, and biomanufacturing. As a notable example, in 2024, Thermo Fisher Scientific Inc., a US-based biotechnology company, unveiled its Gibco Cell Therapy Systems (CTS) Cellmation Software. This particular software stands as a validated automation solution, specifically engineered to connect and integrate workflows across a range of cell therapy instruments, thereby facilitating cGMP compliance. It cohesively links essential instruments, including the CTS DynaCellect Magnetic Separation System, CTS Rotea Counterflow Centrifugation System, CTS Xenon Electroporation System, Heracell Vios CR CO2 Incubator, and Cryomed Controlled-Rate Freezer, all within a unified, user-friendly interface. This integration leads to a reduction in manual touchpoints, estimated at 40 in conventional processes, which in turn minimizes the potential for errors and contamination risks, while simultaneously guaranteeing traceability, repeatability, and 21 CFR Part 11 compliance essential for scaling cGMP manufacturing processes.

Who Are The Primary Competitors In The Global Electrocompetent Cells Market?

Major companies operating in the electrocompetent cells market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Biosciences, Bio-Rad Laboratories Inc., Takara Bio Inc., Promega Corporation, New England Biolabs, OriGene Technologies, MaxCyte, LGC Biosearch Technologies, IBA GmbH, Zymo Research, Creative Biolabs, Inovio Pharmaceuticals Inc., Canvax, Yeastern Biotech, ZellBio GmbH, Scarab Genomics LLC, Intact Genomics.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/electrocompetent-cells-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Electrocompetent Cells Market?

North America was the largest region in the electrocompetent cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electrocompetent cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Electrocompetent Cells Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24214&type=smp

Browse Through More Reports Similar to the Global Electrocompetent Cells Market 2026, By The Business Research Company

Electroceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/electroceuticals-global-market-report

Cell Harvesting Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-harvesting-global-market-report

Hydroelectric Cells Market Report 2026

https://www.thebusinessresearchcompany.com/report/hydroelectric-cells-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795